This evidence prompted us to investigate specific loci encompassing p53 and p73 genes by microsatellite analysis using the fluorescent multiplex PCR technique, and to investigate genetic markers that could help predict the clinical outcome of chemoradiotherapy in bladder cancer. The gene discussed is TP73; the disease is urinary bladder cancer.